General Medicine Raises $120 Million in Series B Funding
General Medicine, a San Francisco-based healthcare platform, has announced the successful closing of a $120 million Series B funding round. This round was led by Andreessen Horowitz, with participation from investors including Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. The company, co-founded by Ashwin Muralidharan and Elliot Cohen, aims to simplify healthcare access by offering services ranging from virtual visits to labs and prescriptions, with transparent pricing and broad insurance acceptance.
Investment Details
The Series B funding round, concluded on October 5, 2026, reflects continued investor confidence in General Medicine's innovative approach to healthcare. Vineeta Agarwala, MD, PhD, a General Partner at Andreessen Horowitz, spearheaded the investment.
Company Background
General Medicine provides a platform where users can easily access a wide range of healthcare services. Customers can compare and purchase these services, which include medications, labs, telehealth, and specialist consultations, with or without insurance. The platform offers over 2,900 products and services, ensuring comprehensive care accessibility.
Strategic Use of Funds
While specific uses for the newly acquired funds were not disclosed, it is likely that the capital will be used to expand General Medicine's service offerings and enhance its nationwide reach. The company's focus on simplifying healthcare access through technology and transparency aligns with broader industry trends towards digitization and consumer-centric care.
Leadership Team
The company is led by co-founder and CEO Ashwin Muralidharan, alongside co-founder and Executive Chair Elliot Cohen. Their leadership has been pivotal in driving General Medicine's growth and innovation since its inception.
For more information on General Medicine's services or to explore their offerings, visit their website at generalmedicine.co.